Targeting EZH2 functions

被引：0
|
作者：
Kleer, C. G.
机构：
来源：
CANCER RESEARCH | 2022年 / 82卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS21-ES13-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ES13-1
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Targeting EZH2 to overcome the resistance to immunotherapy in lung cancer
    Shin, Daniel Sanghoon
    Park, Kevin
    Garon, Edward
    Dubinett, Steven
    SEMINARS IN ONCOLOGY, 2022, 49 (3-4) : 306 - 318
  • [32] EZH2 inhibition: targeting the crossroad of tumor invasion and angiogenesis
    Crea, Francesco
    Fornaro, Lorenzo
    Bocci, Guido
    Sun, Lei
    Farrar, William L.
    Falcone, Alfredo
    Danesi, Romano
    CANCER AND METASTASIS REVIEWS, 2012, 31 (3-4) : 753 - 761
  • [33] Going beyond Polycomb: EZH2 functions in prostate cancer
    Su H. Park
    Ka-Wing Fong
    Ezinne Mong
    M. Cynthia Martin
    Gary E. Schiltz
    Jindan Yu
    Oncogene, 2021, 40 : 5788 - 5798
  • [34] The functions of EZH2 in immune cells: Principles for novel immunotherapies
    Shao, Fang-Fei
    Chen, Bo-Jin
    Wu, Guo-Qing
    JOURNAL OF LEUKOCYTE BIOLOGY, 2021, 110 (01) : 77 - 87
  • [35] Going beyond Polycomb: EZH2 functions in prostate cancer
    Park, Su H.
    Fong, Ka-Wing
    Mong, Ezinne
    Martin, M. Cynthia
    Schiltz, Gary E.
    Yu, Jindan
    ONCOGENE, 2021, 40 (39) : 5788 - 5798
  • [36] MiR-33a functions as a tumor suppressor in triple-negative breast cancer by targeting EZH2
    Zeng, Weihua
    Zou, Guorong
    Cao, Xiaolong
    Li, Weizhan
    CANCER CELL INTERNATIONAL, 2020, 20 (01)
  • [37] MiR-33a functions as a tumor suppressor in triple-negative breast cancer by targeting EZH2
    Zeng Weihua
    Zou Guorong
    Cao Xiaolong
    Li Weizhan
    Cancer Cell International, 20
  • [38] miR-101, downregulated in retinoblastoma, functions as a tumor suppressor in human retinoblastoma cells by targeting EZH2
    Lei, Qiong
    Shen, Fengmei
    Wu, Jie
    Zhang, Weishan
    Wang, Jiahui
    Zhang, Lin
    ONCOLOGY REPORTS, 2014, 32 (01) : 261 - 269
  • [39] Targeting EZH2 and PRC2 dependence as novel anticancer therapy
    Xu, Bowen
    Konze, Kyle D.
    Jin, Jian
    Wang, Gang Greg
    EXPERIMENTAL HEMATOLOGY, 2015, 43 (08) : 698 - 712
  • [40] Precision Targeting with EZH2 and HDAC Inhibitors in Epigenetically Dysregulated Lymphomas
    Lue, Jennifer K.
    Prabhu, Sathyen A.
    Liu, Yuxuan
    Gonzalez, Yulissa
    Verma, Akanksha
    Mundi, Prabhjot S.
    Abshiru, Nebiyu
    Camarillo, JeannieM.
    Mehta, Swasti
    Chen, Emily I.
    Qiao, Changhong
    Nandakumar, Renu
    Cremers, Serge
    Kelleher, Neil L.
    Elemento, Olivier
    Amengual, Jennifer E.
    CLINICAL CANCER RESEARCH, 2019, 25 (17) : 5271 - 5283
12345